Share on LinkedInShare on LinkedIn

ARTICLE · 14 JULY 2026

Courts Deploy Dynamic Blocking Order To Combat Counterfeit Medicines

The UK High Court has approved a groundbreaking dynamic blocking mechanism that allows pharmaceutical companies to block websites selling counterfeit medicines without requiring repeated court applications. This novel approach enables rights holders to self-certify breaches and directly instruct Internet Service Providers to block qualifying websites, marking a significant evolution in combating online pharmaceutical counterfeiting. The decision extends website blocking orders beyond traditional copyright e

United KingdomIntellectual Property

On 23 June 2026, the UK High Court handed down its judgment in Novo Nordisk A/S v British Telecommunications Plc & Ors, extending an existing blocking order to seven additional websites selling counterfeit and unlicensed medicines. More significantly, the court approved a novel ‘dynamic blocking mechanism’, enabling the Applicants to block further websites without the need for further court intervention.

An interesting and central feature of this mechanism is the authority given to the Applicants to (a) assess whether a website meets the confidential blocking criteria and, if so, (b) direct the Respondents, six Internet Service Providers (“ISPs”) to block it without any requirement for a further court order.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from